KSK Diagnostics Exit

KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. In addition to the diagnosis of pathogens, KSK Diagnostics’ point-of-care tests are ideally suited to quickly and reliably clarifying issues related to tumour diagnostics.

Info & Contact

Dr. Stefan Kulick


KSK Diagnostics GmbH
Königstraße 4a
22767 Hamburg

In portfolio

03. Apr 2017 – 24. May 2018